In terms of using these medical devices, India imports almost 80 to 85 percent of them; hence, the government and the private sector are prompted towards the idea...
The Indian medical devices industry is facing a major challenge as the US imposes a 26% tariff on exports, impacting a sector striving to replicate the success of India’s pharmaceutical industry. With India’s medical device exports to the US valued a
The Association Indian Medical Device Industry (AiMED) congratulates the government's announcement to operationalise the...
Glenmark Pharmaceuticals Inc., USA, has announced the commercial availability of Vancomycin Hydrochloride for Injection USP in three single-dose vial strengths: 750 mg/vial, 1.25 g/vial, and 1.5...
The government of India is being urged by its pharmaceutical industry to negotiate with Washington from a position of power on tariffs set to take effect next week, rather than yield to the pressure...
In an interaction with India Pharma Outlook, Sudheendra Kulkarni, MD & CEO of Ferring Pharmaceuticals India shares insights about India's evolution from volume-based to value-based healthcare. He emphasizes the necessity of...
Digital Personal Data Protection Act received the assent of the President on 11th August 2023. This Act provides for the processing of digital personal data in a manner that recognizes both the right of individuals
Indian companies can export pharmaceutical products to Penza region of Russia as many European pharma suppliers have exited the market.
Marksans Pharma has stated that its pharmaceutical manufacturing unit situated at Plot A-1, Phase 1-A, Verna Industrial Estate, Goa, India, has been granted the approval from the...
By the end of this year, India will commence domestic manufacture of Rifampicin, a first-line anti-tubercular medicine. According to official sources, “Rifampicin is at an advanced stage of execution and is expected to get commissioned later this yea
, CDSCO.jpg)
